In the fight against COVID-19, researchers have their newest tool – the supercomputer Fugaku, a project co-developed by Japanese science institute RIKEN and global IT company Fujitsu, utilizing key components developed by Koch company Molex.
Slated for official launch in 2021, the system was made available to researchers a year early to accelerate testing and development of COVID-19 treatment and vaccination options. Once fully operational, Fugaku will harness more than 150,000 central processing units (CPUs), making it the most powerful supercomputer in the world. In June, Fugaku earned that title by performing more than 415 quadrillion (or 415,000 trillion) computations a second – nearly three times quicker than the second-fastest.
Inside the system, Molex provides the backplane cable content that serves as the backbone connecting the system’s circuit boards. In total, Fugaku utilizes 30 standard Molex products and eight specialty connectors and components designed to handle its high bandwidth and data processing demands.
Read more about Fugaku and Molex’s role in the system.